| PDX Collection 0131 (continued) |
| M1A1720 | Lead-induced chronic gout, left ankle and foot, without tophus (tophi) |
| M1A1721 | Lead-induced chronic gout, left ankle and foot, with tophus (tophi) |
| M1A1790 | Lead-induced chronic gout, unspecified ankle and foot, without tophus (tophi) |
| M1A1791 | Lead-induced chronic gout, unspecified ankle and foot, with tophus (tophi) |
| M1A18X0 | Lead-induced chronic gout, vertebrae, without tophus (tophi) |
| M1A18X1 | Lead-induced chronic gout, vertebrae, with tophus (tophi) |
| M1A19X0 | Lead-induced chronic gout, multiple sites, without tophus (tophi) |
| M1A19X1 | Lead-induced chronic gout, multiple sites, with tophus (tophi) |
| P352 | Congenital herpesviral [herpes simplex] infection |
| P353 | Congenital viral hepatitis |
| P358 | Other congenital viral diseases |
| P359 | Congenital viral disease, unspecified |
| P370 | Congenital tuberculosis |
| P371 | Congenital toxoplasmosis |
| P372 | Neonatal (disseminated) listeriosis |
| P373 | Congenital falciparum malaria |
| P374 | Other congenital malaria |
| P378 | Other specified congenital infectious and parasitic diseases |
| P379 | Congenital infectious or parasitic disease, unspecified |
| T560X1A | Toxic effect of lead and its compounds, accidental (unintentional), initial encounter |
| T560X2A | Toxic effect of lead and its compounds, intentional self-harm, initial encounter |
| T560X3A | Toxic effect of lead and its compounds, assault, initial encounter |
| T560X4A | Toxic effect of lead and its compounds, undetermined, initial encounter |
| |
| PDX Collection 0132 |
| A811 | Subacute sclerosing panencephalitis |
| B92 | Sequelae of leprosy |
| B942 | Sequelae of viral hepatitis |
| B948 | Sequelae of other specified infectious and parasitic diseases |
| B949 | Sequelae of unspecified infectious and parasitic disease |
| |
| PDX Collection 0133 |
| A1782 | Tuberculous meningoencephalitis |
| A5042 | Late congenital syphilitic encephalitis |
| A5214 | Late syphilitic encephalitis |
| A759 | Typhus fever, unspecified |
| A799 | Rickettsiosis, unspecified |
| A8100 | Creutzfeldt-Jakob disease, unspecified |
| A8101 | Variant Creutzfeldt-Jakob disease |
| A8109 | Other Creutzfeldt-Jakob disease |
| A811 | Subacute sclerosing panencephalitis |
| A812 | Progressive multifocal leukoencephalopathy |
| A8181 | Kuru |
| A8182 | Gerstmann-Straussler-Scheinker syndrome |
| A8183 | Fatal familial insomnia |
| A8189 | Other atypical virus infections of central nervous system |
| A819 | Atypical virus infection of central nervous system, unspecified |
| A830 | Japanese encephalitis |
| A831 | Western equine encephalitis |
| A832 | Eastern equine encephalitis |
| A833 | St Louis encephalitis |
| A834 | Australian encephalitis |
| A835 | California encephalitis |
| A836 | Rocio virus disease |
| A838 | Other mosquito-borne viral encephalitis |
| A839 | Mosquito-borne viral encephalitis, unspecified |
| A840 | Far Eastern tick-borne encephalitis [Russian spring-summer encephalitis] |
| A841 | Central European tick-borne encephalitis |
| A848 | Other tick-borne viral encephalitis |
| A849 | Tick-borne viral encephalitis, unspecified |
| A850 | Enteroviral encephalitis |
| A851 | Adenoviral encephalitis |
| A852 | Arthropod-borne viral encephalitis, unspecified |
| A858 | Other specified viral encephalitis |
| A872 | Lymphocytic choriomeningitis |
| A880 | Enteroviral exanthematous fever [Boston exanthem] |
| A888 | Other specified viral infections of central nervous system |
| A921 | O'nyong-nyong fever |
| A922 | Venezuelan equine fever |
| A924 | Rift Valley fever |
| A925 | Zika virus disease |
| A928 | Other specified mosquito-borne viral fevers |
| A930 | Oropouche virus disease |
| B004 | Herpesviral encephalitis |
| B0082 | Herpes simplex myelitis |
| B0111 | Varicella encephalitis and encephalomyelitis |
| B0112 | Varicella myelitis |
| B04 | Monkeypox |
| B0601 | Rubella encephalitis |
| B0809 | Other orthopoxvirus infections |
| B0820 | Exanthema subitum [sixth disease], unspecified |
| B0821 | Exanthema subitum [sixth disease] due to human herpesvirus 6 |
| B0822 | Exanthema subitum [sixth disease] due to human herpesvirus 7 |
| B0860 | Parapoxvirus infection, unspecified |
| B0861 | Bovine stomatitis |
| B0862 | Sealpox |
| B0869 | Other parapoxvirus infections |
| B0870 | Yatapoxvirus infection, unspecified |
| B0871 | Tanapox virus disease |
| B0872 | Yaba pox virus disease |
| B0879 | Other yatapoxvirus infections |
| B09 | Unspecified viral infection characterized by skin and mucous membrane lesions |
| B1001 | Human herpesvirus 6 encephalitis |
| B1009 | Other human herpesvirus encephalitis |
| B262 | Mumps encephalitis |
| B2700 | Gammaherpesviral mononucleosis without complication |
| B2701 | Gammaherpesviral mononucleosis with polyneuropathy |
| B2702 | Gammaherpesviral mononucleosis with meningitis |
| B2709 | Gammaherpesviral mononucleosis with other complications |
| B2710 | Cytomegaloviral mononucleosis without complications |
| B2711 | Cytomegaloviral mononucleosis with polyneuropathy |
| B2712 | Cytomegaloviral mononucleosis with meningitis |
| B2719 | Cytomegaloviral mononucleosis with other complication |
| B2780 | Other infectious mononucleosis without complication |
| B2781 | Other infectious mononucleosis with polyneuropathy |
| B2782 | Other infectious mononucleosis with meningitis |
| B2789 | Other infectious mononucleosis with other complication |
| B2790 | Infectious mononucleosis, unspecified without complication |
| B2791 | Infectious mononucleosis, unspecified with polyneuropathy |
| B2792 | Infectious mononucleosis, unspecified with meningitis |
| B2799 | Infectious mononucleosis, unspecified with other complication |
| B331 | Ross River disease |
| B450 | Pulmonary cryptococcosis |
| B452 | Cutaneous cryptococcosis |
| B453 | Osseous cryptococcosis |
| B457 | Disseminated cryptococcosis |
| B458 | Other forms of cryptococcosis |
| B459 | Cryptococcosis, unspecified |
| B582 | Toxoplasma meningoencephalitis |
| B75 | Trichinellosis |
| G0400 | Acute disseminated encephalitis and encephalomyelitis, unspecified |
| G0401 | Postinfectious acute disseminated encephalitis and encephalomyelitis (postinfectious ADEM) |
| G0431 | Postinfectious acute necrotizing hemorrhagic encephalopathy |
| G0481 | Other encephalitis and encephalomyelitis |
| G0489 | Other myelitis |
| G0490 | Encephalitis and encephalomyelitis, unspecified |
| G0491 | Myelitis, unspecified |
| G053 | Encephalitis and encephalomyelitis in diseases classified elsewhere |
| G054 | Myelitis in diseases classified elsewhere |
| G370 | Diffuse sclerosis of central nervous system |
| G374 | Subacute necrotizing myelitis of central nervous system |
| G375 | Concentric sclerosis [Balo] of central nervous system |
| I673 | Progressive vascular leukoencephalopathy |
| J09X3 | Influenza due to identified novel influenza A virus with gastrointestinal manifestations |
| J09X9 | Influenza due to identified novel influenza A virus with other manifestations |
| J102 | Influenza due to other identified influenza virus with gastrointestinal manifestations |
| J1081 | Influenza due to other identified influenza virus with encephalopathy |
| J1082 | Influenza due to other identified influenza virus with myocarditis |
| J1083 | Influenza due to other identified influenza virus with otitis media |
| J1089 | Influenza due to other identified influenza virus with other manifestations |
| J112 | Influenza due to unidentified influenza virus with gastrointestinal manifestations |
| J1181 | Influenza due to unidentified influenza virus with encephalopathy |
| J1182 | Influenza due to unidentified influenza virus with myocarditis |
| J1183 | Influenza due to unidentified influenza virus with otitis media |
| J1189 | Influenza due to unidentified influenza virus with other manifestations |
| L444 | Infantile papular acrodermatitis [Gianotti-Crosti] |
| M1A10X0 | Lead-induced chronic gout, unspecified site, without tophus (tophi) |
| M1A10X1 | Lead-induced chronic gout, unspecified site, with tophus (tophi) |
| M1A1110 | Lead-induced chronic gout, right shoulder, without tophus (tophi) |
| M1A1111 | Lead-induced chronic gout, right shoulder, with tophus (tophi) |
| M1A1120 | Lead-induced chronic gout, left shoulder, without tophus (tophi) |
| M1A1121 | Lead-induced chronic gout, left shoulder, with tophus (tophi) |
| M1A1190 | Lead-induced chronic gout, unspecified shoulder, without tophus (tophi) |
| M1A1191 | Lead-induced chronic gout, unspecified shoulder, with tophus (tophi) |
| M1A1210 | Lead-induced chronic gout, right elbow, without tophus (tophi) |
| M1A1211 | Lead-induced chronic gout, right elbow, with tophus (tophi) |
| M1A1220 | Lead-induced chronic gout, left elbow, without tophus (tophi) |
| M1A1221 | Lead-induced chronic gout, left elbow, with tophus (tophi) |
| M1A1290 | Lead-induced chronic gout, unspecified elbow, without tophus (tophi) |
| M1A1291 | Lead-induced chronic gout, unspecified elbow, with tophus (tophi) |
| M1A1310 | Lead-induced chronic gout, right wrist, without tophus (tophi) |
| M1A1311 | Lead-induced chronic gout, right wrist, with tophus (tophi) |
| M1A1320 | Lead-induced chronic gout, left wrist, without tophus (tophi) |
| M1A1321 | Lead-induced chronic gout, left wrist, with tophus (tophi) |
| M1A1390 | Lead-induced chronic gout, unspecified wrist, without tophus (tophi) |
| M1A1391 | Lead-induced chronic gout, unspecified wrist, with tophus (tophi) |
| M1A1410 | Lead-induced chronic gout, right hand, without tophus (tophi) |
| M1A1411 | Lead-induced chronic gout, right hand, with tophus (tophi) |
| M1A1420 | Lead-induced chronic gout, left hand, without tophus (tophi) |
| M1A1421 | Lead-induced chronic gout, left hand, with tophus (tophi) |
| M1A1490 | Lead-induced chronic gout, unspecified hand, without tophus (tophi) |
| M1A1491 | Lead-induced chronic gout, unspecified hand, with tophus (tophi) |
| M1A1510 | Lead-induced chronic gout, right hip, without tophus (tophi) |
| M1A1511 | Lead-induced chronic gout, right hip, with tophus (tophi) |
| M1A1520 | Lead-induced chronic gout, left hip, without tophus (tophi) |
| M1A1521 | Lead-induced chronic gout, left hip, with tophus (tophi) |
| M1A1590 | Lead-induced chronic gout, unspecified hip, without tophus (tophi) |
| M1A1591 | Lead-induced chronic gout, unspecified hip, with tophus (tophi) |
| M1A1610 | Lead-induced chronic gout, right knee, without tophus (tophi) |
| M1A1611 | Lead-induced chronic gout, right knee, with tophus (tophi) |
| M1A1620 | Lead-induced chronic gout, left knee, without tophus (tophi) |
| M1A1621 | Lead-induced chronic gout, left knee, with tophus (tophi) |
| M1A1690 | Lead-induced chronic gout, unspecified knee, without tophus (tophi) |
| M1A1691 | Lead-induced chronic gout, unspecified knee, with tophus (tophi) |
| M1A1710 | Lead-induced chronic gout, right ankle and foot, without tophus (tophi) |
| M1A1711 | Lead-induced chronic gout, right ankle and foot, with tophus (tophi) |
| M1A1720 | Lead-induced chronic gout, left ankle and foot, without tophus (tophi) |
| M1A1721 | Lead-induced chronic gout, left ankle and foot, with tophus (tophi) |
| M1A1790 | Lead-induced chronic gout, unspecified ankle and foot, without tophus (tophi) |
| M1A1791 | Lead-induced chronic gout, unspecified ankle and foot, with tophus (tophi) |
| M1A18X0 | Lead-induced chronic gout, vertebrae, without tophus (tophi) |
| M1A18X1 | Lead-induced chronic gout, vertebrae, with tophus (tophi) |
| M1A19X0 | Lead-induced chronic gout, multiple sites, without tophus (tophi) |
| M1A19X1 | Lead-induced chronic gout, multiple sites, with tophus (tophi) |
| P352 | Congenital herpesviral [herpes simplex] infection |
| P353 | Congenital viral hepatitis |
| P358 | Other congenital viral diseases |
| P359 | Congenital viral disease, unspecified |
| P370 | Congenital tuberculosis |
| P371 | Congenital toxoplasmosis |
| P372 | Neonatal (disseminated) listeriosis |
| P373 | Congenital falciparum malaria |
| P374 | Other congenital malaria |
| P378 | Other specified congenital infectious and parasitic diseases |
| P379 | Congenital infectious or parasitic disease, unspecified |
| T560X1A | Toxic effect of lead and its compounds, accidental (unintentional), initial encounter |
| T560X2A | Toxic effect of lead and its compounds, intentional self-harm, initial encounter |
| T560X3A | Toxic effect of lead and its compounds, assault, initial encounter |
| T560X4A | Toxic effect of lead and its compounds, undetermined, initial encounter |
| |
| PDX Collection 0134 |
| A8100 | Creutzfeldt-Jakob disease, unspecified |
| A8101 | Variant Creutzfeldt-Jakob disease |
| A8109 | Other Creutzfeldt-Jakob disease |
| A811 | Subacute sclerosing panencephalitis |
| A812 | Progressive multifocal leukoencephalopathy |
| A8181 | Kuru |
| A8182 | Gerstmann-Straussler-Scheinker syndrome |
| A8183 | Fatal familial insomnia |
| A8189 | Other atypical virus infections of central nervous system |
| A819 | Atypical virus infection of central nervous system, unspecified |
| I673 | Progressive vascular leukoencephalopathy |
| |
| PDX Collection 0135 |
| A8100 | Creutzfeldt-Jakob disease, unspecified |
| A8101 | Variant Creutzfeldt-Jakob disease |
| A8109 | Other Creutzfeldt-Jakob disease |
| A811 | Subacute sclerosing panencephalitis |
| A812 | Progressive multifocal leukoencephalopathy |
| A8181 | Kuru |
| A8182 | Gerstmann-Straussler-Scheinker syndrome |
| A8183 | Fatal familial insomnia |
| A8189 | Other atypical virus infections of central nervous system |
| A819 | Atypical virus infection of central nervous system, unspecified |
| A9230 | West Nile virus infection, unspecified |
| A9231 | West Nile virus infection with encephalitis |
| A9232 | West Nile virus infection with other neurologic manifestation |
| A9239 | West Nile virus infection with other complications |
| B9721 | SARS-associated coronavirus as the cause of diseases classified elsewhere |
| I673 | Progressive vascular leukoencephalopathy |
| |
| PDX Collection 0136 |
| A820 | Sylvatic rabies |
| A821 | Urban rabies |
| A829 | Rabies, unspecified |
| |
| PDX Collection 0137 |
| A1782 | Tuberculous meningoencephalitis |
| A5042 | Late congenital syphilitic encephalitis |
| A5214 | Late syphilitic encephalitis |
| A759 | Typhus fever, unspecified |
| A799 | Rickettsiosis, unspecified |
| A811 | Subacute sclerosing panencephalitis |
| A8182 | Gerstmann-Straussler-Scheinker syndrome |
| A8183 | Fatal familial insomnia |
| A8189 | Other atypical virus infections of central nervous system |
| A830 | Japanese encephalitis |
| A831 | Western equine encephalitis |
| A832 | Eastern equine encephalitis |
| A833 | St Louis encephalitis |
| A834 | Australian encephalitis |
| A835 | California encephalitis |
| A836 | Rocio virus disease |
| A838 | Other mosquito-borne viral encephalitis |
| A839 | Mosquito-borne viral encephalitis, unspecified |
| A840 | Far Eastern tick-borne encephalitis [Russian spring-summer encephalitis] |
| A841 | Central European tick-borne encephalitis |
| A848 | Other tick-borne viral encephalitis |
| A849 | Tick-borne viral encephalitis, unspecified |
| A850 | Enteroviral encephalitis |
| A851 | Adenoviral encephalitis |
| A852 | Arthropod-borne viral encephalitis, unspecified |
| A858 | Other specified viral encephalitis |
| A872 | Lymphocytic choriomeningitis |
| A880 | Enteroviral exanthematous fever [Boston exanthem] |
| A888 | Other specified viral infections of central nervous system |
| A921 | O'nyong-nyong fever |
| A922 | Venezuelan equine fever |
| A9230 | West Nile virus infection, unspecified |
| A9231 | West Nile virus infection with encephalitis |
| A9232 | West Nile virus infection with other neurologic manifestation |
| A9239 | West Nile virus infection with other complications |
| A924 | Rift Valley fever |
| A925 | Zika virus disease |
| A928 | Other specified mosquito-borne viral fevers |
| A930 | Oropouche virus disease |
| B004 | Herpesviral encephalitis |
| B0082 | Herpes simplex myelitis |
| B0111 | Varicella encephalitis and encephalomyelitis |
| B0112 | Varicella myelitis |
| B04 | Monkeypox |
| B0601 | Rubella encephalitis |
| B0809 | Other orthopoxvirus infections |
| B0820 | Exanthema subitum [sixth disease], unspecified |
| B0821 | Exanthema subitum [sixth disease] due to human herpesvirus 6 |
| B0822 | Exanthema subitum [sixth disease] due to human herpesvirus 7 |
| B0860 | Parapoxvirus infection, unspecified |
| B0861 | Bovine stomatitis |
| B0862 | Sealpox |
| B0869 | Other parapoxvirus infections |
| B0870 | Yatapoxvirus infection, unspecified |
| B0871 | Tanapox virus disease |
| B0872 | Yaba pox virus disease |
| B0879 | Other yatapoxvirus infections |
| B09 | Unspecified viral infection characterized by skin and mucous membrane lesions |
| B1001 | Human herpesvirus 6 encephalitis |
| B1009 | Other human herpesvirus encephalitis |
| B262 | Mumps encephalitis |
| B2700 | Gammaherpesviral mononucleosis without complication |
| B2701 | Gammaherpesviral mononucleosis with polyneuropathy |
| B2702 | Gammaherpesviral mononucleosis with meningitis |
| B2709 | Gammaherpesviral mononucleosis with other complications |
| B2710 | Cytomegaloviral mononucleosis without complications |
| B2711 | Cytomegaloviral mononucleosis with polyneuropathy |
| B2712 | Cytomegaloviral mononucleosis with meningitis |
| B2719 | Cytomegaloviral mononucleosis with other complication |
| B2780 | Other infectious mononucleosis without complication |
| B2781 | Other infectious mononucleosis with polyneuropathy |
| B2782 | Other infectious mononucleosis with meningitis |
| B2789 | Other infectious mononucleosis with other complication |
| B2790 | Infectious mononucleosis, unspecified without complication |
| B2791 | Infectious mononucleosis, unspecified with polyneuropathy |
| B2792 | Infectious mononucleosis, unspecified with meningitis |
| B2799 | Infectious mononucleosis, unspecified with other complication |
| B331 | Ross River disease |
| B450 | Pulmonary cryptococcosis |
| B452 | Cutaneous cryptococcosis |
| B453 | Osseous cryptococcosis |
| B457 | Disseminated cryptococcosis |
| B458 | Other forms of cryptococcosis |
| B459 | Cryptococcosis, unspecified |
| B582 | Toxoplasma meningoencephalitis |
| B75 | Trichinellosis |
| B9710 | Unspecified enterovirus as the cause of diseases classified elsewhere |
| B9721 | SARS-associated coronavirus as the cause of diseases classified elsewhere |
| G0400 | Acute disseminated encephalitis and encephalomyelitis, unspecified |
| G0401 | Postinfectious acute disseminated encephalitis and encephalomyelitis (postinfectious ADEM) |
| G0431 | Postinfectious acute necrotizing hemorrhagic encephalopathy |
| G0481 | Other encephalitis and encephalomyelitis |
| G0489 | Other myelitis |
| G0490 | Encephalitis and encephalomyelitis, unspecified |
| G0491 | Myelitis, unspecified |
| G053 | Encephalitis and encephalomyelitis in diseases classified elsewhere |
| G054 | Myelitis in diseases classified elsewhere |
| G370 | Diffuse sclerosis of central nervous system |
| G374 | Subacute necrotizing myelitis of central nervous system |
| G375 | Concentric sclerosis [Balo] of central nervous system |
| J09X3 | Influenza due to identified novel influenza A virus with gastrointestinal manifestations |
| J09X9 | Influenza due to identified novel influenza A virus with other manifestations |
| J102 | Influenza due to other identified influenza virus with gastrointestinal manifestations |
| J1081 | Influenza due to other identified influenza virus with encephalopathy |
| J1082 | Influenza due to other identified influenza virus with myocarditis |
| J1083 | Influenza due to other identified influenza virus with otitis media |
| J1089 | Influenza due to other identified influenza virus with other manifestations |
| J112 | Influenza due to unidentified influenza virus with gastrointestinal manifestations |
| J1181 | Influenza due to unidentified influenza virus with encephalopathy |
| J1182 | Influenza due to unidentified influenza virus with myocarditis |
| J1183 | Influenza due to unidentified influenza virus with otitis media |
| J1189 | Influenza due to unidentified influenza virus with other manifestations |
| L444 | Infantile papular acrodermatitis [Gianotti-Crosti] |
| M1A10X0 | Lead-induced chronic gout, unspecified site, without tophus (tophi) |
| M1A10X1 | Lead-induced chronic gout, unspecified site, with tophus (tophi) |
| M1A1110 | Lead-induced chronic gout, right shoulder, without tophus (tophi) |
| M1A1111 | Lead-induced chronic gout, right shoulder, with tophus (tophi) |
| M1A1120 | Lead-induced chronic gout, left shoulder, without tophus (tophi) |
| M1A1121 | Lead-induced chronic gout, left shoulder, with tophus (tophi) |
| M1A1190 | Lead-induced chronic gout, unspecified shoulder, without tophus (tophi) |
| M1A1191 | Lead-induced chronic gout, unspecified shoulder, with tophus (tophi) |
| M1A1210 | Lead-induced chronic gout, right elbow, without tophus (tophi) |
| M1A1211 | Lead-induced chronic gout, right elbow, with tophus (tophi) |
| M1A1220 | Lead-induced chronic gout, left elbow, without tophus (tophi) |
| M1A1221 | Lead-induced chronic gout, left elbow, with tophus (tophi) |
| M1A1290 | Lead-induced chronic gout, unspecified elbow, without tophus (tophi) |
| M1A1291 | Lead-induced chronic gout, unspecified elbow, with tophus (tophi) |
| M1A1310 | Lead-induced chronic gout, right wrist, without tophus (tophi) |
| M1A1311 | Lead-induced chronic gout, right wrist, with tophus (tophi) |
| M1A1320 | Lead-induced chronic gout, left wrist, without tophus (tophi) |
| M1A1321 | Lead-induced chronic gout, left wrist, with tophus (tophi) |
| M1A1390 | Lead-induced chronic gout, unspecified wrist, without tophus (tophi) |
| M1A1391 | Lead-induced chronic gout, unspecified wrist, with tophus (tophi) |
| M1A1410 | Lead-induced chronic gout, right hand, without tophus (tophi) |
| M1A1411 | Lead-induced chronic gout, right hand, with tophus (tophi) |
| M1A1420 | Lead-induced chronic gout, left hand, without tophus (tophi) |
| M1A1421 | Lead-induced chronic gout, left hand, with tophus (tophi) |
| M1A1490 | Lead-induced chronic gout, unspecified hand, without tophus (tophi) |
| M1A1491 | Lead-induced chronic gout, unspecified hand, with tophus (tophi) |
| M1A1510 | Lead-induced chronic gout, right hip, without tophus (tophi) |
| M1A1511 | Lead-induced chronic gout, right hip, with tophus (tophi) |
| M1A1520 | Lead-induced chronic gout, left hip, without tophus (tophi) |
| M1A1521 | Lead-induced chronic gout, left hip, with tophus (tophi) |
| M1A1590 | Lead-induced chronic gout, unspecified hip, without tophus (tophi) |
| M1A1591 | Lead-induced chronic gout, unspecified hip, with tophus (tophi) |
| M1A1610 | Lead-induced chronic gout, right knee, without tophus (tophi) |
| M1A1611 | Lead-induced chronic gout, right knee, with tophus (tophi) |
| M1A1620 | Lead-induced chronic gout, left knee, without tophus (tophi) |
| M1A1621 | Lead-induced chronic gout, left knee, with tophus (tophi) |
| M1A1690 | Lead-induced chronic gout, unspecified knee, without tophus (tophi) |
| M1A1691 | Lead-induced chronic gout, unspecified knee, with tophus (tophi) |
| M1A1710 | Lead-induced chronic gout, right ankle and foot, without tophus (tophi) |
| M1A1711 | Lead-induced chronic gout, right ankle and foot, with tophus (tophi) |
| M1A1720 | Lead-induced chronic gout, left ankle and foot, without tophus (tophi) |
| M1A1721 | Lead-induced chronic gout, left ankle and foot, with tophus (tophi) |
| M1A1790 | Lead-induced chronic gout, unspecified ankle and foot, without tophus (tophi) |
| M1A1791 | Lead-induced chronic gout, unspecified ankle and foot, with tophus (tophi) |
| M1A18X0 | Lead-induced chronic gout, vertebrae, without tophus (tophi) |
| M1A18X1 | Lead-induced chronic gout, vertebrae, with tophus (tophi) |
| M1A19X0 | Lead-induced chronic gout, multiple sites, without tophus (tophi) |
| M1A19X1 | Lead-induced chronic gout, multiple sites, with tophus (tophi) |
| P352 | Congenital herpesviral [herpes simplex] infection |
| P353 | Congenital viral hepatitis |
| P358 | Other congenital viral diseases |
| P359 | Congenital viral disease, unspecified |
![Previous Page [Alt-p]](bakpg.png){kind=small}
![Up a level [Alt-u]](uptop.png){kind=small}
![Next Page [Alt-n]](fwdpg.png){kind=small}